A study published online in the journal Lancet Infectious Diseases found that "full-scale anti-retroviral therapy with three drugs reduces the risk of" an HIV-positive mother passing on the virus to her child during breastfeeding by almost half compared with standard treatment recommendations, MedPage Today reports (Smith, 1/13). "Breastfeeding is vital for child health and development in low-resource settings, but infants born to HIV-positive mothers can be infected through breastfeeding. So a team of researchers from the World Health Organization (WHO) and five study sites in Burkina Faso, Kenya, and South Africa conducted a randomized, controlled trial to investigate whether three antiretroviral (ARV) drugs taken together by women during pregnancy and breastfeeding are more effective than the standard regimen used to prevent mother-to-child HIV transmission in these countries," according to a press release. The researchers found the "cumulative rate of HIV transmission at 12 months of age was 43% lower with the triple-drug regimen compared with the standard regimen," the release notes (1/13). A Lancet Infectious Diseases comment examines the implications of the findings (Becquet/Ekouevi, 1/14).
Back to other news for January 2011
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy